alpha-aminopyridine has been researched along with Heart Failure in 101 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 99 (98.02) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (1.98) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albrecht-Küpper, BE; Diedrichs, N; Gupta, RC; Kohli, S; Rastogi, S; Sabbah, HN; Wang, M; Zhang, K; Zimmermann, K | 1 |
Albrecht-Küpper, B; Dinh, W; Gheorghiade, M; Sabbah, HN; van der Laan, M; Voors, AA | 1 |
Carlier, J; D'Orio, V; el Allaf, D | 1 |
Sharpe, DN | 1 |
Andrews, V; Fishman, AP; Janicki, JS; Kinasewitz, GT; Weber, KT | 1 |
Bijak, A; Czołpiński, T | 1 |
Bayliss, J; Canepa-Anson, R; Dawson, JR; Kuan, P; Norell, MS; Poole-Wilson, PA; Reuben, S; Sutton, GC | 1 |
Scholz, H | 1 |
Alfiero, R; Cocco, G; Padula, A; Rizzo, A; Strozzi, C; Tasini, MT; Urso, L | 1 |
Detry, JM; Mancia, G; Pouleur, H | 1 |
Cocco, G; Sfrisi, C | 1 |
Bova, S; Cargnelli, G; Ferrari, M; Padrini, R; Piovan, D | 1 |
Medina, N; Packer, M; Yushak, M | 4 |
Le Jemtel, TH; Maskin, CS; Sonnenblick, EH | 1 |
Humen, DP; Johnston, DL; Kostuk, WJ | 1 |
Jerie, P | 1 |
Larbig, D; Nasse, H | 1 |
Avery, GS; Brogden, RN; Heel, RC; Speight, TM; Ward, A | 1 |
Taira, N | 1 |
Bashore, TM; Evans, JR; Huss, P; Leier, CV; Pacht, K; Unverferth, DV | 1 |
Benotti, JR; DiBianco, R; Leier, CV; Shabetai, R; Silverman, BD | 1 |
Andrews, V; Janicki, JS; Likoff, MJ; Weber, KT | 1 |
Forman, R; Frishman, W; LeJemtel, TH; Maskin, C; Ribner, H; Siegel, LA; Sonnenblick, EH; Strom, J; Wexler, J | 1 |
Dougherty, AH; Goldstein, RA; Gray, EL; Hanna, JE; Naccarelli, GV | 1 |
Benassi, A; Mattioli, G; Modena, MG | 1 |
Baur, X; Fruhmann, G; Hauser, F; Klepzig, M; Mernitz, G; Strauer, BE | 1 |
Hashimoto, K; Mori, T; Yabuuchi, Y; Yamashita, S | 1 |
Ballard, JO; Carlin, B; Kinney, EL; Zelis, R | 1 |
Bashore, TM; Dalpiaz, K; Hermiller, JB; Huss, P; Leier, CV; Magorien, RD; Unverferth, DV | 1 |
Hermiller, JB; Leier, CV; Leithe, ME; Magorien, RD; Unverferth, DV | 1 |
Andrews, V; Janicki, JS; Likoff, MJ; Rocci, ML; Sutton, MS; Weber, KT; Wilson, H | 1 |
Ansell, J; Benotti, JR; McCue, J; Parrilla, N; Tiarks, C | 1 |
Al-Hasani, SF; Hamblin, AS; Kioy, PG; Lucas, GF; Savidge, GF; Semple, MJ; Webb-Peploe, MM; Wilmshurst, PT | 1 |
Gillmer, DJ; Kark, P | 1 |
Coltart, DJ; Jenkins, BS; Juul, SM; Thompson, DS; Webb-Peploe, MM; Wilmshurst, PT | 1 |
Coltart, DJ; Jenkins, BS; Thompson, DS; Webb-Peploe, MM; Wilmshurst, PT | 1 |
Bayliss, J; Canepa-Anson, R; Norell, M; Poole-Wilson, PA; Reuben, SR; Sutton, GC | 1 |
Hayward, R | 1 |
Webb-Peploe, MM; Wilsmhurst, PT | 1 |
Dunkman, WB; Franciosa, JA; Wilen, MM | 1 |
Peyregne, EA; Reader, C; Suárez, LD | 1 |
Barrett, PA; Chong, B; Lvoff, R; Robinson, PJ | 1 |
Forman, R; Klein, NA; LeJemtel, TH; Maskin, CS; Sonnenblick, EH | 1 |
Andrews, V; Janicki, JS; Weber, KT | 1 |
Maruyama, M; Satoh, K; Taira, N | 1 |
Ballard, JO; Burks, JM; Carlin, B; Hallahan, WF; Kinney, EL; Zelis, R | 1 |
Andrews, V; Fishman, AP; Janicki, JS; Weber, KT; Wilson, JR | 1 |
Frishman, WH; Klein, NA; LeJemtel, TH; Siskind, SJ; Sonnenblick, EH | 1 |
Jentzer, JH; Kirk, ES; Lejemtel, TH; Sonnenblick, EH | 1 |
Benotti, JR; Braunwald, E; Carabello, BA; Colucci, WS; Grossman, W; Malacoff, R; Rude, RE; Wynne, J | 1 |
Forman, R; LeJemtel, TH; Scheuer, J; Siskind, SJ; Sonnenblick, EH | 1 |
Blaufox, JD; Davis, R; Keung, E; LeJemtel, TH; Ribner, HS; Sonnenblick, EH; Wexler, J | 1 |
Benotti, JR; Braunwald, E; Curfman, GD; Grossman, W; Holman, BL; Malacoff, RF; Smith, TW; Wynne, J | 1 |
Benotti, JR; Braunwald, E; Carabello, BA; Grossman, W | 1 |
Efstathakis, D; Feinberg, H; Forman, R; Keung, E; LeJemtel, TH; Siegel, LA; Siskind, SJ; Sonnenblick, EH; Strom, J | 1 |
Alousi, AA; Farah, AE; Lesher, GY; Opalka, CJ | 1 |
Hubenette, A; Lee, S; O'Connor, L; Rubin, SA; Swan, HJ; Tober, J | 1 |
Davis, RS; Forman, R; Greenberg, MA; Keung, EC; LeJemtel, TH; Maskin, CS; Ribner, HS; Schwartz, WJ; Sonnenblick, EH | 1 |
LeJemtel, T; Mancini, D; Sonnenblick, E | 1 |
Braunwald, E; Colucci, WS; Wright, RF | 1 |
Johnston, GD | 1 |
Packer, M | 1 |
Acar, J; Le Potier, J; Michel, PL; Sergent, J; Vahanian, A | 1 |
Janicki, JS; Maskin, CS; Weber, KT | 2 |
Andersson, KE | 1 |
Factor, S; Le Jemtel, TH; Mancini, DM; Sonnenblick, EH | 1 |
LeJemtel, TH; Mancini, DM; Sonnenblick, EH | 1 |
Bassett, AL; Cameron, JS; Gaide, MS; Lodge, NJ | 1 |
Cohen, SR; Das, D; Isner, JM; Konstam, MA; Martin, TT; Salem, DN; Weiland, DS | 1 |
Tommaso, CL | 1 |
Ruggie, N | 1 |
Baim, DS | 1 |
Benotti, J; Benziger, DP; Chatterjee, K; Cody, R; Edelson, J; Hood, WB; Krebs, C; Luczkowec, C; Schwartz, R; Stroshane, R | 1 |
Goldstein, RA | 1 |
Hasegawa, GR | 1 |
Gage, J; LeJemtel, TH; Lucido, D; Rutman, H | 1 |
Aronovitz, MJ; Brockway, BA; Cohen, SR; Das, D; Konstam, MA; Salem, DN | 1 |
Bourassa, M; DiBianco, R; Hess, M; Konstam, M; Likoff, M; Massie, B; Packer, M | 1 |
Treadway, G | 1 |
Bounhoure, JP; Calazel, J; Massabuau, P; Miquel, JP; Puel, J | 1 |
Büll, U; Kleinhans, E; Klepzig, M; Strauer, BE | 1 |
Wilmshurst, P | 1 |
Bassett, AL; Cameron, JS; Gaide, MS; Kimura, S; Kozlovskis, PL; Lodge, NJ; Myerburg, RJ | 1 |
Applefeld, MM | 1 |
Goldfarb, JP; LeJemtel, TH; Manzione, NC; Maskin, CS; Sternlieb, I | 1 |
Franciosa, JA | 1 |
Gerber, L; Merrill, AJ; Silverman, BD | 1 |
Coltart, DJ; Dawson, JR; Dittrich, HC; Jenkins, BS; Juul, SM; Thompson, DS; Walker, JM; Webb-Peploe, MM; Wilmshurst, PT | 1 |
Braunwald, E | 1 |
Alpert, JS; Benotti, JR; McCue, JE | 1 |
Dougherty, AH; Goldstein, RA; Gray, EL; Naccarelli, GV | 1 |
Hafizullah, M; Hussain, M; Jackson, NC; Reynolds, G; Richmond, A; Silke, B; Taylor, SH; Verma, SP | 1 |
Baele, P; Col, J; Goenen, M; Pedemonte, O | 1 |
Alousi, AA; Canter, JM; Fort, DJ | 1 |
Hoffmann, P; Schockenhoff, B | 1 |
20 review(s) available for alpha-aminopyridine and Heart Failure
Article | Year |
---|---|
Partial Adenosine A1 Agonist in Heart Failure.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Aminopyridines; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Coronary Artery Disease; Diabetes Mellitus; Dipeptides; Drug Partial Agonism; Furans; Heart; Heart Failure; Humans; Insulin Resistance; Ischemic Preconditioning, Myocardial; Lipolysis; Mitochondria, Heart; Myocardium; Oxygen Consumption; Pyridines; Renal Insufficiency; Tachycardia, Supraventricular; Thiazoles | 2017 |
The new inotropic phosphodiesterase inhibitors.
Topics: Aminopyridines; Amrinone; Calcium; Carbamates; Cardiotonic Agents; Cardiovascular Agents; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridones; Quinazolines; Stimulation, Chemical; Time Factors; Xanthines | 1984 |
Newer inotropic agents.
Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Dobutamine; Ethanolamines; Heart Failure; Humans; Practolol; Prenalterol; Receptors, Adrenergic, beta | 1984 |
Vasodilator and inotropic agents in treatment of chronic cardiac failure: clinical experience and response in exercise performance.
Topics: Aerobiosis; Aminopyridines; Amrinone; Anaerobiosis; Cardiotonic Agents; Heart Failure; Hemodynamics; Humans; Hydralazine; Neurotransmitter Agents; Physical Exertion; Piperazines; Quinazolines; Sympathetic Nervous System; Vasodilator Agents | 1981 |
[New drugs with positive inotropic action].
Topics: Adrenergic beta-Agonists; Albuterol; Aminopyridines; Amrinone; Cardiotonic Agents; Chronic Disease; Ethanolamines; Heart Failure; Humans; Myocardial Contraction; Practolol; Prenalterol; Stimulation, Chemical; Terbutaline | 1982 |
[Old and new positive inotropic drugs: problems and controversies].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Aminopyridines; Amrinone; Cardiotonic Agents; Glucagon; Glucosides; Heart Failure; Histamine; Humans; Imidazoles; Inosine; Quinazolines; Xanthines | 1984 |
[Positive inotropic therapy of cardiac failure: old and new drugs, controversies and tests].
Topics: Aminopyridines; Amrinone; Cardiac Glycosides; Cardiotonic Agents; Glucagon; Heart Failure; Histamine; Humans; Imidazoles; Inosine; Phosphodiesterase Inhibitors; Quinazolines; Sympathomimetics | 1984 |
[Treatment of refactory heart failure].
Topics: Adult; Aged; Aminopyridines; Amrinone; Captopril; Diet, Sodium-Restricted; Digitalis Glycosides; Diuretics; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance; Female; Heart Failure; Humans; Male; Medication Errors; Middle Aged; Oxygen Inhalation Therapy; Sodium | 1983 |
Amrinone. A preliminary review of its pharmacological properties and therapeutic use.
Topics: Absorption; Aminopyridines; Amrinone; Animals; Calcium; Cardiotonic Agents; Dogs; Dose-Response Relationship, Drug; Guinea Pigs; Half-Life; Heart; Heart Failure; Hemodynamics; Humans; Kinetics; Muscle, Smooth; Muscle, Smooth, Vascular; Papillary Muscles; Physical Exertion; Rabbits; Rats; Regional Blood Flow; Tissue Distribution | 1983 |
[Amrinone, a new cardiotonic agent].
Topics: Aminopyridines; Amrinone; Animals; Cardiotonic Agents; Cats; Guinea Pigs; Heart Failure; Humans; Myocardial Contraction | 1983 |
Intravenous use of amrinone for the treatment of the failing heart.
Topics: Aminopyridines; Amrinone; Cardiac Complexes, Premature; Cardiac Output; Cardiotonic Agents; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Diseases; Heart Failure; Humans; Injections, Intravenous; Myocardial Contraction; Myocardium; Oxygen Consumption; Phosphodiesterase Inhibitors; Pulmonary Wedge Pressure; Thrombocytopenia; Vasodilator Agents | 1985 |
New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Administration, Oral; Aminopyridines; Amrinone; Cardiotonic Agents; Coenzymes; Enoximone; Heart; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Milrinone; Nifedipine; Oxyfedrine; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Quinazolines; Ubiquinone | 1986 |
Vasodilator therapy for primary pulmonary hypertension. Limitations and hazards.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Aminopyridines; Amrinone; Blood Pressure; Calcium Channel Blockers; Captopril; Heart Failure; Hemodynamics; Humans; Hypertension, Pulmonary; Hypotension; Lung; Oxygen; Oxygen Inhalation Therapy; Parasympathomimetics; Prostaglandins; Pulmonary Artery; Vascular Resistance; Vasodilator Agents | 1985 |
Effects of new inotropic agents on exercise performance.
Topics: Adrenergic beta-Agonists; Aminopyridines; Amrinone; Cardiac Output; Cardiotonic Agents; Chronic Disease; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Muscles; Oxygen; Oxygen Consumption; Physical Exertion; Pulmonary Wedge Pressure; Pyridones; Time Factors | 1986 |
Some new positive inotropic agents.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Aminopyridines; Amrinone; Cardiotonic Agents; Dobutamine; Dopamine; Drug Tolerance; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Practolol; Prenalterol; Pyridones | 1986 |
Central and peripheral components of cardiac failure.
Topics: Aminopyridines; Amrinone; Animals; Captopril; Cardiac Output; Cardiomegaly; Cardiotonic Agents; Catecholamines; Coronary Circulation; Diuretics; Drug Therapy, Combination; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Isotonic Contraction; Microcirculation; Muscles; Norepinephrine; Oxygen Consumption; Renal Circulation; Vasodilator Agents | 1986 |
Non-glycoside, non-catecholamine inotropic agents in the treatment of congestive heart failure.
Topics: Administration, Oral; Aminopyridines; Amrinone; Arrhythmias, Cardiac; Calcium; Cardiac Output; Cardiotonic Agents; Cyclic AMP; Dose-Response Relationship, Drug; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Milrinone; Physical Exertion; Pyridones; Thrombocytopenia; Time Factors | 1986 |
Congestive heart failure.
Topics: Aminopyridines; Amrinone; Angiotensin-Converting Enzyme Inhibitors; Cardiac Glycosides; Cardiotonic Agents; Diuretics; Dobutamine; Dopamine; Heart Failure; Humans; Hydralazine; Milrinone; Nitrates; Nitroprusside; Prazosin; Pyridones; Sympathomimetics; Vasodilator Agents | 1986 |
Clinical effects of intravenous amrinone in patients with congestive heart failure.
Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Electrophysiology; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Myocardium; Oxygen Consumption | 1986 |
Milrinone, a new agent for the treatment of congestive heart failure.
Topics: Aminopyridines; Amrinone; Animals; Cardiotonic Agents; Heart Failure; Hemodynamics; Humans; Milrinone; Pyridones | 1986 |
10 trial(s) available for alpha-aminopyridine and Heart Failure
Article | Year |
---|---|
Chronic oral amrinone therapy in congestive heart failure: a double-blind placebo-controlled withdrawal study.
Topics: Administration, Oral; Adult; Aged; Aminopyridines; Amrinone; Cardiotonic Agents; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Platelet Count; Substance Withdrawal Syndrome | 1984 |
Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study.
Topics: Adult; Aged; Aminopyridines; Amrinone; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Random Allocation | 1984 |
Intravenous amrinone for congestive heart failure.
Topics: Administration, Oral; Aminopyridines; Amrinone; Cardiotonic Agents; Clinical Trials as Topic; Heart Failure; Humans; Injections, Intravenous | 1984 |
Amrinone therapy for congestive heart failure in outpatients with idiopathic dilated cardiomyopathy.
Topics: Aminopyridines; Amrinone; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Female; Heart Failure; Humans; Male; Middle Aged; Physical Exertion | 1983 |
Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate.
Topics: Adult; Aged; Aminopyridines; Amrinone; Cardiotonic Agents; Chronic Disease; Drug Therapy, Combination; Ethanolamines; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1983 |
Pharmacokinetics of the bipyridines amrinone and milrinone.
Topics: Administration, Oral; Aminopyridines; Amrinone; Clinical Trials as Topic; Half-Life; Heart Failure; Humans; Infusions, Parenteral; Kinetics; Male; Milrinone; Pyridones; Random Allocation; Time Factors | 1986 |
Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial.
Topics: Administration, Oral; Aminopyridines; Amrinone; Cardiotonic Agents; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Stroke Volume; Time Factors | 1985 |
Clinical safety of intravenous amrinone--a review.
Topics: Aminopyridines; Amrinone; Arrhythmias, Cardiac; Cardiotonic Agents; Clinical Trials as Topic; Drug Interactions; Gastrointestinal Diseases; Heart Failure; Humans; Hypotension; Thrombocytopenia | 1985 |
[Effects of amrinone administered orally and by injection in heart failure].
Topics: Administration, Oral; Aged; Aminopyridines; Amrinone; Cardiotonic Agents; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Injections, Intravenous; Middle Aged; Thrombocytopenia | 1985 |
Intravenous amrinone in left ventricular failure complicated by acute myocardial infarction.
Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dose-Response Relationship, Drug; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Random Allocation; Stroke Volume; Vascular Resistance | 1985 |
71 other study(ies) available for alpha-aminopyridine and Heart Failure
Article | Year |
---|---|
Chronic therapy with a partial adenosine A1-receptor agonist improves left ventricular function and remodeling in dogs with advanced heart failure.
Topics: Adenosine A1 Receptor Agonists; Aminopyridines; Animals; Dogs; Echocardiography, Doppler; Heart Failure; Hemodynamics; Stroke Volume; Thiazoles; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2013 |
Clinical studies with beta 2 adrenoceptor agonists in heart failure.
Topics: Adrenergic beta-Agonists; Albuterol; Aminopyridines; Amrinone; Cardiotonic Agents; Ethanolamines; Heart Failure; Hemodynamics; Humans; Middle Aged; Myocardial Infarction | 1982 |
Inotropic drugs in the treatment of heart failure.
Topics: Adrenergic beta-Agonists; Aminopyridines; Amrinone; Cardiac Glycosides; Cardiotonic Agents; Cyclic AMP; Heart Failure; Humans; Imidazoles; Ion Channels; Myocardial Contraction; Phosphodiesterase Inhibitors; Receptors, Adrenergic, alpha | 1984 |
Inotropic drugs of the future.
Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Heart Failure; Humans; Imidazoles; Practolol; Prenalterol; Propanolamines; Xamoterol | 1982 |
[New inotropic drugs].
Topics: Aminopyridines; Amrinone; Calcium; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Drug Evaluation; Heart Failure; Humans; Phosphodiesterase Inhibitors; Sympathomimetics | 1982 |
Correction of dilutional hyponatremia in severe chronic heart failure by converting-enzyme inhibition.
Topics: Adult; Aged; Aminopyridines; Amrinone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiotonic Agents; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Hyponatremia; Male; Middle Aged; Prazosin; Proline | 1984 |
Inotropic drugs for treatment of the failing heart.
Topics: Aminophylline; Aminopyridines; Amrinone; Cardiotonic Agents; Catecholamines; Digitalis Glycosides; Glucagon; Heart Failure; Hemodynamics; Humans; Milrinone; Myocardial Contraction; Pyridones; Receptors, Adrenergic, beta; Theophylline | 1984 |
Amrinone therapy in patients with heart failure. Lack of improvement in functional capacity and left ventricular function at rest and during exercise.
Topics: Administration, Oral; Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Cerebral Ventriculography; Drug Evaluation; Echocardiography; Electrocardiography; Heart Failure; Heart Function Tests; Heart Rate; Humans; Male; Middle Aged; Oxygen Consumption; Physical Exertion; Radionuclide Imaging | 1984 |
[Alternatives to digitalis therapy].
Topics: Aminopyridines; Amrinone; Captopril; Catecholamines; Diuretics; Heart Failure; Humans; Hydralazine; Nitrates; Nitroprusside; Practolol; Prazosin; Prenalterol; Vasodilator Agents | 1983 |
Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Cardiac Output; Chronic Disease; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Renin; Stroke Volume; Time Factors; Vasodilator Agents | 1984 |
Amrinone: a promising new cardiotonic agent in the treatment of chronic cardiac failure.
Topics: Activities of Daily Living; Aminopyridines; Amrinone; Animals; Cardiotonic Agents; Cats; Chronic Disease; Dose-Response Relationship, Drug; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Long-Term Care; Male; Middle Aged; Myocardial Contraction; Oxygen Consumption | 1983 |
Improvement in exercise capacity despite cardiac deteriora tion: nonivasive assessment of long-term therapy with amrinone in severe heart failure.
Topics: Adult; Aminopyridines; Amrinone; Cardiotonic Agents; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Long-Term Care; Male; Middle Aged; Stroke Volume | 1983 |
Amrinone: acute electrophysiologic and hemodynamic effects in patients with congestive heart failure.
Topics: Adult; Aminopyridines; Amrinone; Atrioventricular Node; Cardiotonic Agents; Electrocardiography; Female; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Pulmonary Wedge Pressure; Tachycardia; Vascular Resistance | 1984 |
Failure of low doses of amrinone to produce sustained hemodynamic improvement in patients with severe chronic congestive heart failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Cardiotonic Agents; Chronic Disease; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Wedge Pressure; Vascular Resistance | 1984 |
Echocardiographic evaluation of cardiovascular effects of amrinone.
Topics: Adult; Aminopyridines; Amrinone; Cardiac Catheterization; Cardiomyopathy, Dilated; Cardiotonic Agents; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction | 1984 |
[Right ventricular hemodynamics and lung function following amrinone injection].
Topics: Airway Resistance; Aminopyridines; Amrinone; Cardiotonic Agents; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Lung Diseases, Obstructive; Lung Volume Measurements; Myocardial Contraction | 1984 |
Positive inotropic effect of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure.
Topics: Administration, Oral; Aminopyridines; Amrinone; Animals; Blood Pressure; Cardiotonic Agents; Dobutamine; Dogs; Dose-Response Relationship, Drug; Heart Failure; Heart Rate; Injections, Intravenous; Male; Myocardial Contraction; Pyrazines; Quinolines | 1984 |
Amrinone-mediated thrombocytopenia.
Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Heart Failure; Humans; Platelet Count; Thrombocytopenia | 1983 |
Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Stroke Volume; Time Factors; Vascular Resistance | 1984 |
Amrinone in the treatment of chronic cardiac failure.
Topics: Aged; Aminopyridines; Amrinone; Cardiotonic Agents; Chronic Disease; Double-Blind Method; Drug Evaluation; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Outpatients; Oxygen Consumption; Random Allocation | 1984 |
Amrinone-induced thrombocytopenia.
Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Platelets; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Immunoglobulin G; Indium; Male; Middle Aged; Platelet Count; Prospective Studies; Radioisotopes; Thrombocytopenia | 1984 |
The effects of amrinone on platelet count, survival and function in patients with congestive cardiac failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Platelets; Cardiotonic Agents; Cell Survival; Female; Heart Failure; Humans; Male; Middle Aged; Platelet Count; Prospective Studies | 1984 |
Dangers of amrinone.
Topics: Aminopyridines; Amrinone; Cardiomyopathy, Dilated; Cardiotonic Agents; Heart Failure; Humans | 1984 |
Comparison of the effects of amrinone and sodium nitroprusside on haemodynamics, contractility, and myocardial metabolism in patients with cardiac failure due to coronary artery disease and dilated cardiomyopathy.
Topics: Adult; Aminopyridines; Amrinone; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Female; Ferricyanides; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Nitroprusside | 1984 |
Haemodynamic effects of intravenous amrinone in patients with impaired left ventricular function.
Topics: Adult; Aminopyridines; Amrinone; Cardiotonic Agents; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction | 1983 |
Amrinone--promising innovation for treatment of the failing heart.
Topics: Aminopyridines; Amrinone; Heart Failure; Humans; Kinetics; Myocardial Contraction; Stimulation, Chemical | 1983 |
Side effects of amrinone therapy.
Topics: Administration, Oral; Adult; Aged; Aminopyridines; Amrinone; Cardiotonic Agents; Female; Heart Failure; Humans; Hypotension; Infusions, Parenteral; Male; Middle Aged; Thrombocytopenia | 1983 |
Adverse effects of long-term amrinone administration in congestive heart failure.
Topics: Abdomen; Aged; Aminopyridines; Amrinone; Cough; Heart Failure; Humans; Liver Function Tests; Male; Middle Aged; Nausea; Pain; Time Factors; Vomiting | 1983 |
Amrinone therapy in congestive cardiomyopathy.
Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Female; Heart Failure; Humans; Middle Aged | 1983 |
Amrinone--a new inotropic agent in chronic resistant congestive cardiac failure.
Topics: Administration, Oral; Aminopyridines; Amrinone; Cardiotonic Agents; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Thrombocytopenia | 1981 |
Long-term amrinone therapy in patients with severe heart failure: drug-dependent hemodynamic benefits despite progression of disease.
Topics: Administration, Oral; Adult; Aminopyridines; Amrinone; Cardiotonic Agents; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Physical Exertion | 1982 |
Cardiotonic agents in the management of chronic cardiac failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dobutamine; Ethanolamines; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Kidney Function Tests; Male; Middle Aged; Oxygen Consumption | 1982 |
The improvement of cardiac performance by amrinone, a new cardiotonic drug, in an experimental failing heart preparation of the dog.
Topics: Aminopyridines; Amrinone; Animals; Cardiac Output; Cardiotonic Agents; Dogs; Heart Failure; Heart Rate; Myocardial Contraction | 1982 |
Clinical experience with amrinone in patients with advanced congestive heart failure.
Topics: Administration, Oral; Aged; Aminopyridines; Amrinone; Cardiotonic Agents; Heart Failure; Humans; Infusions, Parenteral; Middle Aged | 1982 |
Amrinone and exercise performance in patients with chronic heart failure.
Topics: Aminopyridines; Amrinone; Chronic Disease; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Pulmonary Wedge Pressure; Thrombocytopenia | 1981 |
Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure.
Topics: Adolescent; Adult; Aged; Aminopyridines; Amrinone; Cardiac Output; Catecholamines; Chronic Disease; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Pulmonary Wedge Pressure; Time Factors | 1981 |
Beneficial effect of amrinone on myocardial oxygen consumption during acute left ventricular failure in dogs.
Topics: Acute Disease; Aminopyridines; Amrinone; Animals; Blood Circulation; Coronary Circulation; Dogs; Female; Heart Failure; Heart Ventricles; Male; Myocardium; Oxygen Consumption | 1981 |
Problems in assessment of new pharmacologic agents for the heart failure patient.
Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Cardiovascular Agents; Drug Evaluation; Energy Metabolism; Ethanolamines; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Prazosin; Vasodilator Agents | 1981 |
Acute substantial benefit of inotropic therapy with amrinone on exercise hemodynamics and metabolism in severe congestive heart failure.
Topics: Adolescent; Adult; Aminopyridines; Amrinone; Blood Pressure; Exercise Test; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Lactates; Lactic Acid; Male; Middle Aged; Myocardial Contraction; Pulmonary Wedge Pressure; Vascular Resistance | 1981 |
Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure.
Topics: Administration, Oral; Aged; Aminopyridines; Blood Pressure; Cardiac Output; Cardiotonic Agents; Female; Heart; Heart Failure; Heart Rate; Humans; Kidney; Male; Middle Aged; Time Factors; Vascular Resistance | 1980 |
Oral amrinone in refractory congestive heart failure.
Topics: Aged; Aminopyridines; Amrinone; Blood Pressure; Coronary Disease; Electrocardiography; Female; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Radionuclide Imaging; Time Factors | 1980 |
Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.
Topics: Aged; Aminopyridines; Amrinone; Blood Pressure; Cardiac Output; Coronary Circulation; Coronary Disease; Electrocardiography; Energy Metabolism; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Oxygen Consumption; Stroke Volume; Vascular Resistance | 1980 |
Beneficial effects of amrinone-hydralazine combination on resting hemodynamics and exercise capacity in patients with severe congestive heart failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Cardiac Output; Cardiotonic Agents; Drug Therapy, Combination; Exercise Test; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Pulmonary Wedge Pressure; Rest; Vascular Resistance | 1981 |
Cardiotonic activity of amrinone--Win 40680 [5-amino-3,4'-bipyridine-6(1H)-one].
Topics: Adenosine Triphosphatases; Adrenergic beta-Antagonists; Aminopyridines; Anesthesia; Animals; Blood Pressure; Cardiotonic Agents; Cats; Cyclic AMP; Dogs; Electrophysiology; Female; Heart Failure; Heart Rate; Histamine Antagonists; Injections, Intravenous; Male; Monoamine Oxidase; Myocardial Contraction; Phosphoric Diester Hydrolases; Reserpine | 1979 |
Thrombocytopenia and fever in a patient taking amrinone.
Topics: Aminopyridines; Cardiotonic Agents; Fever; Heart Failure; Humans; Male; Middle Aged; Thrombocytopenia | 1979 |
Hemodynamic effects of intravenous and oral amrinone in patients with severe heart failure: relationship between intravenous and oral administration.
Topics: Administration, Oral; Aminopyridines; Amrinone; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male | 1979 |
Alternatives to the digitalis glycosides for heart failure.
Topics: Adrenergic beta-Agonists; Aminopyridines; Amrinone; Cardiotonic Agents; Heart Failure; Humans; Milrinone; Pyridones | 1985 |
[Positive inotropic agents. Generalities and classification].
Topics: Adrenergic beta-Agonists; Aminopyridines; Amrinone; Calcium; Cardiotonic Agents; Digitalis Glycosides; Dobutamine; Ethanolamines; Heart Failure; Heart Ventricles; Humans; Myocardial Contraction; Phosphodiesterase Inhibitors; Practolol; Prenalterol | 1985 |
New positive inotropic drugs for the treatment of congestive heart failure.
Topics: Aminopyridines; Amrinone; Cardiac Output; Cardiotonic Agents; Dipeptides; Dobutamine; Enalapril; Heart Failure; Humans; Milrinone; Myocardial Contraction; Pyridones; Stimulation, Chemical; Vascular Resistance; Vasodilator Agents | 1985 |
Enhanced relaxation and reduced positive inotropic effects of amrinone in ventricular muscle from cats with subacute heart failure. Implications for drug therapy.
Topics: Aminopyridines; Amrinone; Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Cats; Cyclic AMP; Heart Failure; Heart Ventricles; Isoproterenol; Myocardial Contraction; Potassium | 1985 |
Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Cardiac Output; Cardiotonic Agents; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Nitroprusside; Radionuclide Imaging; Sodium Pertechnetate Tc 99m; Stroke Volume; Vascular Resistance; Vasodilation | 1986 |
Effects of amrinone on myocardial energetics in severe congestive heart failure.
Topics: Aminopyridines; Amrinone; Animals; Cardiotonic Agents; Coronary Circulation; Dogs; Enoximone; Heart; Heart Failure; Humans; Imidazoles; Isoproterenol; Milrinone; Myocardial Contraction; Myocardium; Oxygen Consumption; Phosphodiesterase Inhibitors; Pyridones | 1985 |
Comparative immediate hemodynamic and hormonal effects of amrinone and captopril in patients with severe chronic heart failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Captopril; Cardiac Output; Cardiotonic Agents; Female; Follow-Up Studies; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Renin; Renin-Angiotensin System; Time Factors; Vascular Resistance | 1986 |
Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Dobutamine; Drug Synergism; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Stroke Volume | 1986 |
Effect of amrinone on right ventricular function: predominance of afterload reduction.
Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Nitroprusside; Stroke Volume; Vascular Resistance | 1986 |
New positive inotropic agents for congestive heart failure.
Topics: Aminopyridines; Amrinone; Animals; Cardiotonic Agents; Drug Evaluation; Heart Failure; Humans; Milrinone; Pyridones | 1986 |
[Amrinone in acute and long-term therapy].
Topics: Administration, Oral; Aminopyridines; Amrinone; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Exercise Test; Half-Life; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Long-Term Care | 1985 |
Alternative to the digitalis glycosides for heart failure.
Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Digitalis Glycosides; Heart Failure; Humans | 1985 |
Effects of amrinone on contraction and K+-induced contracture of normal and subacutely failed cat ventricular muscle.
Topics: Aminopyridines; Amrinone; Animals; Cardiotonic Agents; Cats; Dogs; Dose-Response Relationship, Drug; Guinea Pigs; Heart Failure; Hemodynamics; Isoproterenol; Myocardial Contraction; Nadolol; Ouabain; Potassium; Propanolamines | 1986 |
Chronic congestive heart failure. Where have we been? Where are we heading?
Topics: Aminopyridines; Amrinone; Biopsy; Calcium Channel Blockers; Cardiology; Chronic Disease; Digitalis; Dobutamine; Dopamine; Forecasting; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Myocardial Contraction; Myocardium; Plants, Medicinal; Plants, Toxic; Prognosis; Quality of Life; Vasodilator Agents | 1986 |
The effects of two new inotropic agents on microsomal liver function in patients with congestive heart failure.
Topics: Adult; Aged; Aminopyridines; Aminopyrine; Amrinone; Breath Tests; Cardiac Output; Cardiotonic Agents; Heart Failure; Humans; Liver; Liver Function Tests; Male; Microsomes, Liver; Middle Aged; Milrinone; Pyridones | 1986 |
Intravenous amrinone: an advance or a wrong step?
Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Heart Failure; Humans; Infusions, Parenteral; Vasodilator Agents | 1985 |
Clinical effects and side effects of amrinone. A study of 24 patients with chronic congestive heart failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Arrhythmias, Cardiac; Cardiotonic Agents; Chronic Disease; Electrocardiography; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Radionuclide Imaging; Stroke Volume | 1985 |
Effects of intracoronary and intravenous amrinone infusions in patients with cardiac failure and patients with near normal cardiac function.
Topics: Adult; Aminopyridines; Amrinone; Angina Pectoris; Blood Pressure; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Circulation; Heart Failure; Hemodynamics; Humans; Infusions, Intra-Arterial; Infusions, Parenteral; Lactates; Male; Middle Aged; Vascular Resistance | 1985 |
A symposium: Amrinone. Introduction.
Topics: Aminopyridines; Amrinone; Diuretics; Heart Failure; Humans; Vasodilator Agents | 1985 |
Comparative vasoactive therapy for heart failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Cardiotonic Agents; Catecholamines; Dobutamine; Dopamine; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Pulmonary Wedge Pressure; Tachycardia; Vascular Resistance | 1985 |
Electrophysiologic effects of amrinone.
Topics: Adult; Aged; Aminopyridines; Amrinone; Arrhythmias, Cardiac; Cardiac Output; Cardiac Pacing, Artificial; Cardiotonic Agents; Electrocardiography; Electrophysiology; Female; Heart Conduction System; Heart Failure; Humans; Male; Middle Aged | 1985 |
Pathophysiology of cardiac failure.
Topics: Aminopyridines; Amrinone; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dobutamine; Dopamine; Furosemide; Heart; Heart Failure; Humans; Myocardial Contraction; Nitroprusside; Norepinephrine; Oxygen Consumption; Vascular Resistance; Vasoconstriction | 1985 |
Amrinone in the management of low cardiac output after open heart surgery.
Topics: Adult; Aged; Aminopyridines; Amrinone; Cardiac Output; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Female; Heart Failure; Humans; Male; Middle Aged; Postoperative Complications; Pulmonary Wedge Pressure; Shock, Cardiogenic; Time Factors; Vascular Resistance | 1985 |
The beneficial effect of amrinone on acute drug-induced heart failure in the anaesthetised dog.
Topics: Aminopyridines; Amrinone; Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Central Venous Pressure; Dogs; Female; Heart Failure; Male; Pentobarbital; Procainamide; Propranolol; Vascular Resistance; Verapamil | 1985 |
[Amrinone in catecholamine refractory heart failure in septic shock].
Topics: Adult; Aged; Aminopyridines; Amrinone; Cardiotonic Agents; Catecholamines; Dose-Response Relationship, Drug; Drug Resistance; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Respiratory Insufficiency; Shock, Septic | 1985 |